Post has attachment
Natco 藥廠有限公司發起了一個通用版sofosbuvir 400毫克/ velpatasvir 100 mg固定量的組合.
它將市場的產品下#velpanat品牌名稱和售價為mrp盧比. 25,000 (373美元)相當於一瓶28粒.
推出的是以下非專屬授權協議, 它natco已經與gilead sciences inc. 習慣, 製造和銷售通用版本的後者的慢性c型肝炎藥在101發展中國家. [固定量的組合是賣的gilead sciences inc. 下epclusa品牌名稱. Epclusa是第一個全口腔, 泛genotypic, 單一的平板電腦養生法的待遇的成年人和基因型1-6慢性c型肝炎病毒(hcv)感染.
#velpanat #velpanatprice #velpatasvir #velpatasvirinindia #natco #c型肝炎, #velpanatinchina, #中國, #俄羅斯#烏克蘭, #土耳其#澳洲#美國, #velpanat供應商, #經銷商, #代理, #出口國, #velpanatsupplier
#sofosvel, #panovir.
欲知更多詳情:
Whatsapp: + 918652682666
Qq: 3357955411
電子郵件: hepcinatlp786@gmail.com

VELPANAT ( Velpatasvir100mg+Sofosbuvir400mg):

Natco Pharma Ltd has launched a generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination.

It will market the product under the #VELPANAT brand name and priced at an MRP of Rs.25,000 ( USD $373 ) equivalent for a bottle of 28 tablets.

The launch is under a non-exclusive licensing agreement that Natco has with Gilead Sciences Inc. to manufacture and sell generic versions of the latter’s chronic hepatitis C medicines in 101 developing countries. The fixed dose combination is sold by Gilead Sciences Inc. under the Epclusa brand name. Epclusa is the first all-oral, pan-genotypic, single tablet regimen for the treatment of adults with genotype 1-6 chronic hepatitis C virus (HCV) infection.

#Velpanat #Velpanatprice #Velpatasvir #VelpatasvirinIndia #Natco #Hepatitis C, #VelpanatinChina, #China, #Russia, #Ukraine, #Turkey, #Australia, #USA, #Velpanat Supplier, #Distributor, #Wholesaler, #Exporter, #Velpanatsupplier, #Delhi #Mumbai #Hyderabad #VelpanatinINdia #Spexib #Crizalk #Geftinat #Hepcinat #Sofosbuvir
#Sofosvel, #Panovir.

For more details:
Whatsapp: +918652682666
QQ: 3357955411
Email: hepcinatlp786@gmail.com
Photo
Photo
2/27/17
2 Photos - View album
Wait while more posts are being loaded